Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa
- PMID: 19261799
- PMCID: PMC2681833
- DOI: 10.1128/JCM.02280-08
Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa
Abstract
Fluoroquinolones are not indicated for use for the treatment of pneumonia in children; however, non-levofloxacin-susceptible Streptococcus pneumoniae (NLSSP) has emerged in South Africa among children receiving treatment for multidrug-resistant tuberculosis. This study aimed to genotypically characterize NLSSP isolates. Invasive isolates were collected through active national laboratory-based surveillance for invasive pneumococcal disease (IPD) from 2000 through 2006 (n = 19,404). Carriage studies were conducted at two hospitals for patients with tuberculosis in two provinces. Phenotypic characterization was performed by determination of MICs and serotyping. Fluoroquinolone resistance mutations were identified, and clonality was investigated by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. Twelve non-levofloxacin-susceptible cases of IPD were identified, and all were in children <15 years of age. Ten isolates were serotype 19F and formed two clusters according to their PFGE profiles, antibiogram types, and fluoroquinolone resistance-conferring mutations. All nine carriage isolates from children in hospital A were NLSSP, serotype 19F, were indistinguishable by PFGE, and were related to invasive isolates in cluster 2. Of 26 child carriers in hospital B, 22 (85%) were colonized with NLSSP. The isolates were indistinguishable by PFGE, although they displayed two serotypes, serotypes 19F and 23F. The isolates were related to invasive isolates in cluster 1; however, higher levofloxacin MICs and different fluoroquinolone resistance mutations were suggestive of horizontal gene transfer. A serotype 23F carriage isolate displayed increased fitness compared with the fitness of an otherwise indistinguishable serotype 19F carriage isolate. These data suggest that a low-level non-levofloxacin-susceptible strain transformed into a highly resistant strain under antibiotic pressure and underwent capsular switching in order to have increased fitness.
Figures


Similar articles
-
Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.Int J Antimicrob Agents. 2008 Jul;32(1):62-7. doi: 10.1016/j.ijantimicag.2008.01.013. Epub 2008 Mar 12. Int J Antimicrob Agents. 2008. PMID: 18339522
-
An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.J Clin Microbiol. 2010 Jan;48(1):184-91. doi: 10.1128/JCM.01011-09. Epub 2009 Nov 4. J Clin Microbiol. 2010. PMID: 19889905 Free PMC article.
-
Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.Lancet. 2008 Mar 29;371(9618):1108-13. doi: 10.1016/S0140-6736(08)60350-5. Epub 2008 Mar 21. Lancet. 2008. PMID: 18359074
-
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan.Clin Microbiol Infect. 2010 Jul;16(7):973-8. doi: 10.1111/j.1469-0691.2009.02951.x. Epub 2009 Sep 23. Clin Microbiol Infect. 2010. PMID: 19778298
-
Molecular typing of the pneumococcus and its application in epidemiology in sub-Saharan Africa.Front Cell Infect Microbiol. 2013 Mar 14;3:12. doi: 10.3389/fcimb.2013.00012. eCollection 2013. Front Cell Infect Microbiol. 2013. PMID: 23503978 Free PMC article. Review.
Cited by
-
Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Infection. 2012 Jun;40(3):239-62. doi: 10.1007/s15010-012-0257-2. Epub 2012 Mar 30. Infection. 2012. PMID: 22460782 Review.
-
Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.Antimicrob Agents Chemother. 2012 Oct;56(10):5088-95. doi: 10.1128/AAC.06463-11. Epub 2012 Jul 16. Antimicrob Agents Chemother. 2012. PMID: 22802256 Free PMC article.
-
International pneumococcal clones match or exceed the fitness of other strains despite the accumulation of antibiotic resistance.Antimicrob Agents Chemother. 2011 Oct;55(10):4915-7. doi: 10.1128/AAC.00250-11. Epub 2011 Aug 8. Antimicrob Agents Chemother. 2011. PMID: 21825290 Free PMC article.
-
Global fluoroquinolone resistance epidemiology and implictions for clinical use.Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14. Interdiscip Perspect Infect Dis. 2012. PMID: 23097666 Free PMC article.
-
Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain.Emerg Infect Dis. 2014 Nov;20(11):1848-56. doi: 10.3201/eid2011.131215. Emerg Infect Dis. 2014. PMID: 25340616 Free PMC article.
References
-
- Calfee, D. P. 2005. Rifamycins, p. 374-388. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed. Elsevier Churchill Livingstone, Philadelphia, PA.
-
- Chen, F. J., and H. J. Lo. 2003. Molecular mechanisms of fluoroquinolone resistance. J. Microbiol. Immunol. Infect. 361-9. - PubMed
-
- Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
-
- Duesberg, C. B., S. Malhotra-Kumar, H. Goossens, L. McGee, K. P. Klugman, T. Welte, and M. W. Pletz. 2008. Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes. Antimicrob. Agents Chemother. 524191-4193. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical